Metastatic Kidney Cancer x Uromigos 2025 UPDATES (Part 2)
Two Onc Docs
00:00
Navigating TKI Side Effects and Non-Clear Cell RCC Treatments
This chapter delves into the side effects associated with tyrosine kinase inhibitors (TKIs) in metastatic kidney cancer treatment. It emphasizes the complexity of non-clear cell renal cell carcinoma (RCC) and the necessity for tailored therapeutic approaches based on the latest trials and immune therapies.
Transcript
Play full episode
